SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: TradeOfTheDay who wrote (965)12/13/1997 12:50:00 AM
From: BDR  Read Replies (2) | Respond to of 7041
 
<<Zonagen, Inc. specializes in products and services for the management of
reproductive health. Its technologies focus on the areas of urology, female health
and contraception. In addition to Vasomax, its oral therapeutic for male erectile
dysfunction, the Company is developing novel fertility diagnostics and
therapeutics, contraceptives and new therapeutics for benign prostatic
hyperplasia, sexually transmitted diseases and prostate cancer.>>

Could someone help me here. Does Zonagen have any product(s) on the market now in any of these areas mentioned? How much revenue do these products presently generate?